Clinical Trial Update: Low-Dose Naltrexone For ME/CFS: Dose-Finding [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of low-dose naltrexone for myalgic encephalomyelitis/chronic fatigue syndrome; the study is not yet recruiting and aims to identify t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myalgic Encephalomyelitis Chronic Fatigue Syndrome

Drugs mentioned

• Low Dose Naltrexone (naltrexone)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | Phase 2 | Status: NOT_YET_RECRUITING